Auriclosene
- Generic Name
- Auriclosene
- Drug Type
- Small Molecule
- Chemical Formula
- C4H9Cl2NO3S
- CAS Number
- 846056-87-9
- Unique Ingredient Identifier
- BKR7Y95229
- Background
Auriclosene has been used in trials studying the treatment of Impetigo, Bacterial Conjunctivitis, Asymptomatic Bacteriuria, and Adenoviral Conjunctivitis.
FDA Clears NovaBay's Novel Dual-Action Eye Infection Treatment NVC-422 for Clinical Trials
• NovaBay Pharmaceuticals receives FDA clearance for Investigational New Drug application of NVC-422, triggering a $1 million milestone payment from licensing partner Alcon.
• NVC-422, the lead Aganocide compound, shows promise as the first treatment targeting both viral and bacterial conjunctivitis, addressing a significant gap in current therapeutic options.
• The development targets the $1+ billion global ophthalmic anti-infective market, offering potential solution to increasing antibiotic resistance in bacterial conjunctivitis treatment.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath